Advanced BioDesign Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Employees
  • 13
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $9.8M
Latest Deal Amount
  • Investors
  • 1

Advanced BioDesign General Information

Description

Developer of novel anticancer drugs intended to focus specifically on targeting ALDH as a therapeutic approach for acute myeloid leukaemia and other cancers with high unmet medical needs. The company's therapeutic approach focuses on the discovery and production of the recombinant molecules for acute myeloid leukaemia and other cancers with high unmet medical needs, enabling institutions in the field of immunology to overcome tumour chemoresistance and to restore or activate endogenous cell death mechanisms in cancer cells.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Parc Technologique de Lyon, Bâtiment D
  • 655 Allée des Parcs
  • 69800 Saint-Priest
  • France
+33 04 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Advanced BioDesign Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 25-Feb-2020 $9.8M 000.00 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 17-Dec-2013 000.00 000.00 000.00 Completed Generating Revenue
To view Advanced BioDesign’s complete valuation and funding history, request access »

Advanced BioDesign Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
ADP D 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
ADP B 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
To view Advanced BioDesign’s complete cap table history, request access »

Advanced BioDesign Executive Team (3)

Name Title Board Seat Contact Info
Ismail Ceylan Co-Founder, Chief Executive Officer & Chairman
Guillaume Martin Co-Founder, Chief Operating Officer & Board Member
Mileidys Perez Alea Ph.D Co-Founder, Chief Scientific Officer, Scientific Director and Member of the Scientific Committee
To view Advanced BioDesign’s complete executive team members history, request access »

Advanced BioDesign Board Members (9)

Name Representing Role Since
Gerard Quash Self Board Member 000 0000
Guillaume Martin Advanced BioDesign Co-Founder, Chief Operating Officer & Board Member 000 0000
Ismail Ceylan Advanced BioDesign Co-Founder, Chief Executive Officer & Chairman 000 0000
Jacques Simonnet Xerys Gestion Board Member 000 0000
Mileidys Perez Alea Ph.D Advanced BioDesign Co-Founder, Chief Scientific Officer, Scientific Director and Member of the Scientific Committee 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Advanced BioDesign Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Advanced BioDesign Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Xerys Gestion PE/Buyout Minority 000 0000 000000 0
To view Advanced BioDesign’s complete investors history, request access »